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October 20111230 AbstractsConclusions:Quantifiable and reproducible radiation scatter is created
during interventional procedures. Radiation doses vary widely around the
perimeter of the angiography table andmay be referred to as “scatter cloud.”
This “scatter cloud” differs from the levels predicted by the inverse square
law. Knowledge of the actual exposure levels within the endovascular
environment may help in mitigating these risks.
Comparative Analysis of Endarterectomy and Stenting For the Treat-
ment of Carotid Stenosis in Women
Ageliki Vouyouka, Natalia Egorova, Alan Moskowitz, Annetine Gelijns, Mi-
chael Marin, Peter Faries, Mount Sinai School of Medicine, New York, NY
Introduction and objectives: Although large randomized studies
have established the efficacy and safety of carotid endarterectomy (CEA) and
stenting (CAS), the under-representation of women leaves the comparison
of risks to benefits of performing these procedures on women an open
question. To address this issue, we delineated patient characteristics predict-
ing outcomes in women undergoing carotid interventions.
Methods:We analyzed in-hospital mortality, postoperative stroke, and
the composite end points of stoke or death in 20,620 hospitalizations in
New York and Florida for 2007 to 2009. Univariate and multivariable
logistic regression analyses were performed.
Results: CEAs were performed in 16,576 asymptomatic and in 1744
symptomatic women and CAS in 1948 asymptomatic and in 352 symptom-
atic women. Compared with CAS, CEA rates were significantly lower for
in-hospital mortality, stroke, and combined stroke/mortality (Table). Car-
diac complication rates did not differ among asymptomatic women, but
cardiac complications were more frequent among symptomatic women with
CAS (10.5% vs 6.5%, P .008). Among symptomatic women, the presence
of renal disease, CAD, or age80 years increased the risk of CAS over CEA
threefold for the composite end point of stroke or death. For asymptomatic
women, only in those with CAD or diabetes, there was a significant differ-
ence in the mortality/stroke rates favoring CEA. After adjusting for relevant
clinical and demographic risk factors, CAS increased the risk for the com-
posite end point of stoke or death in both symptomatic and asymptomatic
patients.
Conclusions: These databases reflect real-world practice performance
of the management of carotid disease in women and suggest that CEA has
better perioperative outcomes in women. Importantly, CAS is associated
with significant morbidity in certain clinical settings, and this should be
taken into account when choosing a revascularization procedure.
In-hospital outcomes after carotid endarterectomy (CEA) and carotid
artery stenting (CAS) in asymptomatic and symptomatic women
Table.
Outcome
Asymptomatic Symptomatic
CEA, % CAS, % P CEA, % CAS, % P
Mortality 0.3 0.8 .0007 0.4 3.4 .0001
Post-op
stroke
1.5 2.6 .0004 3.5 9.7 .0001
Stroke/
mortality
1.7 3.1 .0001 3.8 11.1 .0001
Comparison of Carotid Endarterectomy and Stenting in Real-World
Practice Using a Regional Quality-Improvement Registry
Brian W. Nolan,1 Randall R. De Martino,1 Philip P. Goodney,1 David
Butzel,2 Andres Schanzer,3 David H. Stone,1 Christopher J. Kwolek,4
Richard J. Powell,1 Jack L. Cronenwett,1 1Dartmouth-Hitchcock Medical
Center, Lebanon, NH; 2Maine Medical Center, Portland, Me; 3University
of Massachusetts Memorial Medical Center, Worcester, Mass; 4Massachu-
setts General Hospital, Boston, Mass
Introduction and objectives: Carotid artery stenting (CAS) remains
controversial despite recent randomized controlled trials. This study com-
pared the outcomes of CAS and carotid endarterectomy (CEA) in real-world
practice.
Methods: This was a retrospective analysis of 7649 CEA and 430 CAS
procedures performed at 17 centers from 2003 to 2010 within the Vascular Study
Group of New England. Two primary outcomemeasures were (1) any in-hospital
stroke or death, and (2) any stroke, death, permanent cranial nerve injury (CNI), or
myocardial infarction (MI). Combined coronary artery bypass grafting and CEA
procedures were excluded. Multivariate analysis was performed to identify predic-
tors of in-hospital stroke/death in patients undergoing CAS.
Results: Patients undergoing CAS had increased prevalence of coronary
artery disease, congestive heart failure, diabetes mellitus, and prior ipsilateral
CEA. CAS was performed in six centers by 30 surgeons and 8 interventionalists
with a case volume per operator ranging from1 to 137. Embolic protectionwas
used in 97% of CAS. Shunts were used in 48% of CEA. The overall in-hospital
C
vtroke/death rate was higher amongpatients undergoingCAS (2.3% vs 1.1%,P
028), which was due to an increased risk of stroke/death in symptomatic
atients. Asymptomatic patients had similar rates of stroke/death with CEA
nd CAS. Overall rates of stroke, death, MI, and CNI were not different
etween CEA and CAS. Cortical symptoms (odds ratio [OR]; 7.3; 95%
onfidence interval [CI], 1.8-29.3), age 70 years (OR, 5.3; 95% CI,
.1-26.3), and CHF (OR, 3.9; 95% CI, 1.0-15.0) were predictors of
troke/death in patients undergoing CAS (Table).
able. Outcomes of carotid endarterectomy (CEA) and
arotid artery stenting (CAS) within the ascular Study
roup of New England
Variable No.
Overall
(n  8,079), %
Asymptomatic
(n  5,316), %
Symptomatic
(n  2,761), %
Stroke,
death
Stroke,
death,
CNI, MI
Stroke,
death
Stroke,
death,
CNI, MI
Stroke,
death
Stroke,
death,
CNI,
MI
CEA 7649 1.1 4.1 0.89 3.6 1.6 5.0
CAS 430 2.3 2.8 0.73 1.1 5.1 5.8
P .028 0.183 .784 .027 .001 .654
NI, Cranial nerve injury; myocardial infarction;MI,myocardial infarction.
Conclusions: In our regional vascular registry, CAS is performed in
atients at high operative risk. The overall outcomes of CAS and CEA are
imilar when accounting for permanent CNI and MI. However, symptom-
tic patients treated with CAS are at higher risk stroke or death. CAS may be
est suited for asymptomatic patients.
atients Considered “High Risk” For Carotid Endarterectomy are at
ncreased Risk of Adverse Events After Carotid Artery Stenting
hunsuke Yoshida, Christoph S. Nabzdyk, Julia D. Glaser, Rodney P.
ensley, Allen D. Hamdan, Frank B. Pomposelli, Mark C. Wyers, Elliot L.
haikof, Marc L. Schermerhorn, Beth Israel Deaconess Medical Center,
oston, Mass
Introduction and objectives: Current guidelines allow stenting as an
lternative in patients considered “high risk” for carotid endarterectomy
CEA). There is conflicting evidence regarding high-risk criteria for CEA
nd the safety of stenting in these patients. Using CMS inclusion criteria for
arotid artery stenting (CAS), we stratified patients that underwent CAS or
EA by risk status and compared their outcomes.
Methods: A retrospective record review of all CAS and CEA proce-
ures from 2001 through 2010 at a tertiary medical center was performed.
atients were identified using International Classification of Diseases, 9th
evision, Clinical Modification codes and stratified according to Centers for
edicare and Medicaid Services high-risk status and adjusted for symptom
tatus. We compared differences in outcomes among each subgroup of
atients that underwent CAS or CEA. Multivariable logistic regression was
sed to determine predictors of death alone or combined 30-day adverse
vents of cerebrovascular accident (CVA) or transient ischemic attack (TIA),
yocardial infarction (MI), or death.
Results: We identified 307 CAS patients (61.9% high-risk) and 1018 CEA
atients (25.8% high-risk). Complications occurred in 18 of 190 high-risk CAS
atients (9.5%), including 9 CVAs (4.7%), 4 TIAs (2.1%), 3 MIs (1.6%), and 4
eaths (2.1%).Complicationsoccurred in14of 263high-riskCEApatients (5.3%),
ncluding10CVAs (3.8%), 3TIAs (1.1%), 1MI (0.4%), and1death (0.4%;Table).
hysiologic high-risk status predicted adverse events after CAS (odds ratio [OR]
.54; 95% confidence interval [CI], 1.01-6.42; P .047) but not after CEA (OR,
.89; 95% CI, 0.59-2.16; P  .36). Controlling for physiologic high-risk and
ymptomstatus revealedCAShad an increased risk of deathoverCEA(OR,10.13;
5% CI, 1.07-95.61; P .04).
able.
Variable No.
Symptomatic
(%)
CVA
(%)
TIA
(%)
Death
(%)
MI
(%)
Combined
(%)
CAS risk
High 190 35.2 4.7 2.1 2.1 1.6 9.5
Low 117 24.8 0.0 3.4 0.0 0.0 4.3
CEA risk
High 263 41.4 3.8 1.1 0.4 0.4 5.3
Low 755 36.7 2.8 1.2 0.0 1.1 5.1AS, Carotid artery stenting; CEA, carotid endarterectomy; CVA, cerebro-
ascular accident;MI,myocardial infarction; TIA, transient ischemic attack.
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JOURNAL OF VASCULAR SURGERY
Volume 54, Number 4 Abstracts 1231Conclusions: Current CMS physiologic high-risk CEA criteria place
patients at increased risk for adverse events for CAS. This warrants the need
to reconsider patient selection criteria for CAS vs CEA in physiologically
high-risk patients.
Short-term Dietary Manipulations can Attenuate the Adipose Inflam-
matory Response to Surgical Trauma
Binh Nguyen, Peng Yu, Ming Tao, Godfrey Ilonzo, C. Keith Ozaki,
Brigham and Women’s Hospital, Boston, Mass
Introduction and objectives: Morbid obesity is frequently associated
with increased surgical morbidity and mortality, and adipose is increasingly
recognized as an organ that plays an important mechanistic role in host
inflammation. We thus hypothesized that diet-induced obesity drives an
accentuated proinflammatory adipose response to surgical trauma and that
short-term dietary intervention by switching from a high-fat diet to a normal
diet can attenuate this response.
Methods: Standard surgical manipulations were performed on the left
flank fat pad of 26-week-old C57Bl6 male mice fed normal chow for 20
weeks (n  6), high-fat chow for 20 weeks (60% Kcal; n  6), or high-fat
chow for 17 weeks reversed to normal chow for 3 weeks (n  6). Day 1
adipose was collected and the expression of the proinflammatory cytokines
interleukin (IL)-1, IL-6, and tumor necrosis factor(TNF)-, and of the
anti-inflammatory cytokine IL-10 was assessed using quantitative RT-PCR
(individually normalized to day 0 adipose).
Results: Expression of all assayed mediators was induced by surgical
trauma. Adipose from the group fed high-fat chow yielded an exaggerated
proinflammatory cytokine signature compared with controls fed normal
chow (P  .002 for IL-1a and IL-6). Short-term dietary reversal signifi-
cantly attenuated the IL-1 (P  .002) and IL-6 induction (P  .015).
Conclusion: Surgery induces proinflammatory and anti-inflammatory
cytokine expression, and diet-induced obesity is associated with an accentu-
ated proinflammatory cytokine response to surgical trauma. Short-term
dietary switch to a normal chow diet attenuates this response. These results
support a nimble adipose phenotype and suggest that periprocedural dietary
interventions could affect surgical outcomes (Fig).
A Novel Model of Hind Limb Ischemia to Test Human Therapeutic
Angiogenesis
Robert A. Brenes,1 Mackenzie Bear,2 Caroline Jadlowiec,2 Peter Hashim,2
Alan Dardik,2 1Saint Mary’s Hospital, Waterbury, Conn; 2Yale University
School of Medicine, New Haven, Conn
Introduction and objectives: Clinical trials injecting bone marrow-
derived mononuclear cells (MNC) for therapeutic angiogenesis in patients
with critical limb ischemia are currently underway. However, there are
limited animal models available that adequately model human disease to
allow direction of the human studies.
Methods:C57BL/6male mice (aged 6-8 weeks) underwent unilateral
high femoral artery ligation and excision; the contralateral leg was used as a
control. MNC were isolated from donor mice, suspended in Roswell Park
Memorial Institute 1640, and injected into the gastrocnemius. Control
Fig.injections used an equal volume of medium without cells. MNC were
characterized using fluorescence-activated cell-sorting analysis. Muscle
p
slood flow was measured with “deep probe” laser Doppler. Functional
arlov, ischemia, and modified ischemia scales were recorded at intervals
efore the operation and to 4 weeks after. Mice were euthanized at 1, 2, and
weeks for histologic analysis. Statistics were based on five random fields of
iew at original magnification 40.
Results: Blood flow was significantly higher in MNC-injected mice
han in controls (P .0001). Tarlov scores were statistically higher through-
ut the first week postoperatively in MNC mice (P  .0064). Ischemia
cores were significantly higher in MNCmice (P .0269). Average number
f muscle fibers was lower and fiber area was higher in MNCmice (n 3) at
ll intervals (P  .01).
Conclusions: High femoral ligation and excision is a reproducible
odel of limb ischemia in C57BL/6 mice that shows response to MNC
njection. These studies suggest several parameters of human trials can be
ested in a small animal model in a cost-effective manner, allowing optimi-
ation of human trial parameters.
itrosylative Stress During Ischemia–Reperfusion Injury: Implications
or Poly (Adenosine Diphosphate-Ribose) Polymerase and Nitric Ox-
de Synthase Activity
hirling Tsai, Chandler A. Long, Hyung-Jin Yoo, Rahmi Oklu, Michael T.
atkins, Hassan Albadawi, Massachusetts General Hospital, Boston, Mass
Introduction and objectives: Poly (adenosine diphosphate [ADP]-
ibose) polymerase (PARP) inhibition is cytoprotective during limb ischemia–
eperfusion (IR) injury. Paradoxically, PARP activation may be triggered by
ysfunctional nitric oxide synthase (NOS) activity. These experiments were
ndertaken to assess whether NOS inhibition will ameliorate skeletal muscle
njury and alter PARP activity during the acute and early chronic phases of
eperfusion in a mouse model of hind limb IR.
Methods: Two groups of C57BL6 mice were underwent to 1.5 hours
f hind limb ischemia, followed by reperfusion. Mice were treated with the
OS inhibitor NG-nitro-L-Arginine methyl ester (L-NAME, 50 mg/kg/d
 10) or normal saline (n  10) starting 1 day before IR. Hind limb
uscles were harvested after 1 day or 7 days of reperfusion for histologic
valuation of skeletal muscle fiber injury and protein expression. PARP
ctivity was assessed by Western blotting for poly-ADP-ribosylated (PAR)
roteins. NOS activity was evaluated by measuring tissue nitrite, the expres-
ion of total-nNOS and the activating pS1412 and the inhibitory pS847-
NOS sites. Evidence of nitrosative stress was estimated byWestern blotting
or nitrotyrosine. Data were analyzed by Student t test.
Results:L-NAME treatment resulted in an 80% increase in the number
f injured fibers compared with nitrotyrosine at day 1 IR (P  .02.) There
as no difference in PARP activity at days 1 or 7 between the two groups.
urthermore, there was no significant difference in nitrite, nitrotyrosine, or
he expression of total or pS1412-nNOS, but there was significantly less
S847-nNOS expression in the L-NAME group at day 7 (P  .0003).
Conclusions: L-NAME treatment exacerbates skeletal muscle fiber
njury after IR but does not alter PARP activity. Because NOS inhibition
pharmacologic and through phosphorylation) does not alter nitrite or
itrotyrosine levels after injury, NOS and interactions may be partially
OS-independent during acute IR.
Western blotting data are expressed as average specific bands densities 
tandard error. *P .001 compared with NS.
mall Interfering RNA Coating of Prosthetic Arterial Graft Materials
aggie Chun,1 Christoph S. Nabzdyk,1 Juila D. Glaser,1 Saif Pathan,2
atthew Phaneuf,2 Leena Pradhan,1 Frank W. LoGerfo,1 1Beth Israel
eaconess Medical Center, Boston, Mass; 2BioSurfaces, Inc, Ashland, Mass
Introduction and objectives: Intimal hyperplasia (IH) remains the
eading cause for prosthetic arterial graft failure. Electrospinning of the
acron-based polymer, polyethylene terephthalate (ePET), is an appealing
lternative to woven or knitted Dacron or polytetrafluoroethylene (PTFE)
rafts. RNA interference is a promising tool to silence genes contributing to
H. Combining these technologies thus seemed logical. In this study, ePET
nd commercially available PTFE fabrics were dipped into various small
nterfering (si) RNA formulations, and adsorption of siRNA to the materials
as investigated.
Methods: PTFE and ePET fabrics were incubated for 50 minutes in
olutions containing unlabeled siRNA, siGLO Red (DyLight-547 tagged)
ransfection indicator siRNA, or cholesterol-siRNA-DyLight-547. siRNA
as used without a transfection reagent or was complexed with JetPEI, a
ationic polymer. siRNA concentrations were measured before and after
abric incubation to determine total adsorption. In a different experiment,
PET samples were dipped into siGLO Red/PEI solutions once for 50
inutes or repeatedly, 10 times for 5 minutes each, with intermittent washes
n NaCl. Confocal microscopy was performed and red fluorescent density
etermined.
Results: Unlabeled siRNA was not adsorbed to fabrics unless com-
lexed with PEI, whereas siGLO Red and Chol-siRNA-DyLight547 had
ome affinity to the materials. Overall, siRNA adsorption to ePET and PTFE
